Cargando…
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
SIMPLE SUMMARY: The use of cannabidiol (CBD)-rich hemp-based nutraceuticals is increasing in dogs and cats for disorders related to anxiety, seizures, cancer and pain. To date, there is little information related to appropriate dosing or long-term effects on serum chemistry or complete blood counts...
Autores principales: | Deabold, Kelly A., Schwark, Wayne S., Wolf, Lisa, Wakshlag, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826847/ https://www.ncbi.nlm.nih.gov/pubmed/31635105 http://dx.doi.org/10.3390/ani9100832 |
Ejemplares similares
-
Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
por: Wang, Tongxin, et al.
Publicado: (2022) -
Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
por: Wakshlag, Joseph J., et al.
Publicado: (2020) -
Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract – A Case Series
por: Smith, Gregory L., et al.
Publicado: (2021) -
Oral CBD-rich hemp extract modulates sterile inflammation in female and male rats
por: Hopkins, Shelby, et al.
Publicado: (2023) -
Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022)